CN102511858A - 一种适合孕妇食用的红枣浓浆及其生产工艺 - Google Patents
一种适合孕妇食用的红枣浓浆及其生产工艺 Download PDFInfo
- Publication number
- CN102511858A CN102511858A CN2011104608455A CN201110460845A CN102511858A CN 102511858 A CN102511858 A CN 102511858A CN 2011104608455 A CN2011104608455 A CN 2011104608455A CN 201110460845 A CN201110460845 A CN 201110460845A CN 102511858 A CN102511858 A CN 102511858A
- Authority
- CN
- China
- Prior art keywords
- temperature
- jujube
- vitamin
- sterilization
- jujube juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000005516 engineering process Methods 0.000 title claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 240000008866 Ziziphus nummularia Species 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 61
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 54
- 235000020418 red date juice Nutrition 0.000 claims abstract description 52
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 42
- 241001247821 Ziziphus Species 0.000 claims abstract description 33
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960003080 taurine Drugs 0.000 claims abstract description 27
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 21
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000011575 calcium Substances 0.000 claims abstract description 21
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 21
- 229960000304 folic acid Drugs 0.000 claims abstract description 21
- 235000019152 folic acid Nutrition 0.000 claims abstract description 21
- 239000011724 folic acid Substances 0.000 claims abstract description 21
- 239000011701 zinc Substances 0.000 claims abstract description 21
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 21
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 20
- 229960005069 calcium Drugs 0.000 claims abstract description 20
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 19
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 18
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 18
- 239000011719 vitamin A Substances 0.000 claims abstract description 18
- 229940045997 vitamin a Drugs 0.000 claims abstract description 18
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 13
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 30
- 229910052742 iron Inorganic materials 0.000 claims description 30
- 230000001954 sterilising effect Effects 0.000 claims description 30
- 238000004659 sterilization and disinfection Methods 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 29
- 239000003292 glue Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000012141 concentrate Substances 0.000 claims description 21
- 235000008504 concentrate Nutrition 0.000 claims description 16
- 238000004140 cleaning Methods 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 239000002002 slurry Substances 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 235000021433 fructose syrup Nutrition 0.000 claims description 10
- 235000021552 granulated sugar Nutrition 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 9
- 235000012907 honey Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 6
- 229960003284 iron Drugs 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 241000238631 Hexapoda Species 0.000 claims description 4
- 241000700159 Rattus Species 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 4
- 239000002518 antifoaming agent Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 230000002950 deficient Effects 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract description 27
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract description 24
- 235000016709 nutrition Nutrition 0.000 abstract description 16
- 235000015097 nutrients Nutrition 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 11
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 8
- 230000035764 nutrition Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract description 6
- 235000005282 vitamin D3 Nutrition 0.000 abstract description 6
- 239000011647 vitamin D3 Substances 0.000 abstract description 6
- 229940021056 vitamin d3 Drugs 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 4
- 235000019789 appetite Nutrition 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 229940114079 arachidonic acid Drugs 0.000 abstract description 3
- 235000021342 arachidonic acid Nutrition 0.000 abstract description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 2
- -1 phosphatide Chemical compound 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 235000003715 nutritional status Nutrition 0.000 abstract 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000012010 growth Effects 0.000 description 11
- 230000035935 pregnancy Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 208000007502 anemia Diseases 0.000 description 8
- 210000003754 fetus Anatomy 0.000 description 8
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 206010039966 Senile dementia Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000035790 physiological processes and functions Effects 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 230000008774 maternal effect Effects 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 3
- 206010036600 Premature labour Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 238000007872 degassing Methods 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 208000026278 immune system disease Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 208000026440 premature labor Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000035606 childbirth Effects 0.000 description 2
- 230000008131 children development Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000000276 neural tube Anatomy 0.000 description 2
- 230000009984 peri-natal effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000855583 Homo sapiens Cysteine sulfinic acid decarboxylase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000037063 Thinness Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007235 immunity generation Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 206010048828 underweight Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种适合孕妇食用的红枣浓浆及其生产工艺,属于食品加工技术领域。本发明针对我国目前孕妇营养状况,以现代营养科学理论为指导,精选孕妇所需营养素DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌等,以药食同源的浓缩枣汁为载体,合理搭配组方,研制开发出即营养全面、功能协调,有具有很好适口性、有助于孕妇健脾益胃、调理肠胃、带来好胃口的红枣浓浆新型产品。各营养素经过科学配伍,采用现代食品加工工艺加工而成,充分发挥其协同作用,达到全面改善孕妇营养状况、补血补气、调节肠道、提高机体免疫力等功能作用,便于服用、便于携带、利于吸收。
Description
技术领域
本发明涉及一种红枣浓浆及其生产工艺,尤其适合孕妇食用,属于食品加工技术领域。
背景技术
孕妇和乳母均为需要加强营业的特殊人群,胎儿生长发育所需的各种营养素均来自母体,孕妇本身也需为分娩和分泌乳汁贮备一定的营养素;乳母则需分泌乳汁供给幼儿的生长发育。从某种程度上,孕妇和乳母的营养状况决定着一个民族的身体素质和智力素质。孕产期营养保健质量不仅影响胎儿生长发育,而且对整个儿童期、乃至成人期的健康都产生久远的影响,合理、全面的膳食是孕产期营养保健的关键。关注研究孕妇、乳母的营养对优生优育具有重要的意义。孕妇、乳母作为特殊人群,其营养需求旺盛,容易出现氨基酸、维生素、矿物质等营养素不足的问题。这些营养素最然人体需求量很少,但一旦缺乏就会对人体健康造成极大的影响,对妊娠哺乳期妇女及处生长发育阶段的幼儿就更为重要。
本发明克服现有技术不足,以红枣汁为载体合理配合各种人体所需营养素,提供一种适合孕妇食用的红枣浓浆及其生产工艺。
发明内容
本发明目的在于提供一种适合孕妇食用的红枣浓浆及其生产工艺。
所述适合孕妇食用的红枣浓浆,含有DHA 0.1%~0.8%、AA 0.1%~0.5%、磷脂0.1%~1%、维生素A 0.00005%~0.002%、维生素D3 0.000005%~0.00002%、叶酸0.0001%~0.01%、牛磺酸0.1%~1.5%、钙0.5%~1.5%、铁0.005%~0.5%、锌0.005%~0.5%,余量为浓缩枣汁,总量为100%;
DHA即二十二碳六烯酸,AA即二十碳四烯酸;
所述钙源为葡萄糖酸钙、碳酸钙、碳酸氢钙、柠檬酸钙、乳酸钙、乙酸钙等法规允许使用的原料;
所述铁源为硫酸亚铁、乳酸亚铁、柠檬酸铁、富马酸亚铁、葡萄糖酸亚铁、柠檬酸铁铵等法规允许使用的原料;
所述锌源为硫酸锌、葡萄糖酸锌、乳酸锌法规允许使用的原料;
所述适合孕妇食用的红枣浓浆还含有白砂糖10%~25%、高果糖浆10%~25%、柠檬酸1%~6%、葡萄糖1%~5%、蜂蜜0.1%~0.5%中的一种或几种;
%含义为重量百分比;
本发明所述适合孕妇食用的红枣浓浆生产工艺,包括以下步骤:
(1)调配;
所述调配为按配方准确称取各原料,将DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌分别或几种混合后用适量(一般可为5~10倍重量)浓缩枣汁溶解、混匀,再加入到加热至75~80℃左右的浓缩枣汁中,搅拌均匀;
如果配方中还含有白砂糖、高果糖浆、柠檬酸、葡萄糖、蜂蜜中的一种或几种,则先将白砂糖、高果糖浆、柠檬酸、葡萄糖、蜂蜜中的一种或几种与浓缩枣汁混合均匀后,再将DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌分别或几种混合后用适量(一般可为5~10倍重量)浓缩枣汁溶解、混匀,再加入到加热至75~80℃左右的浓缩枣汁中,搅拌均匀;
(2)胶磨;
所述胶磨为用胶体磨研磨;
胶磨前最好要确保料液的固形物含量70~75°Bx;调整磨盘刻度到最佳时,开始胶磨;胶磨时,注意调节合适的细度,太粗解决不了问题,太细容易造成液体外溢,不利于生产;一定要调到合适的细度;胶磨完成后,把磨盘调松,用冷水冲洗干净,以备下次使用;浓浆胶磨时主要有两个目的:第一,物料通过胶磨后,浆液内的胶体,在一定外力的作用下,各种小微粒,被磨碎,彼此之间与糖液形成了更加均一,稳定的混合物,起到均质的作用;第二,物料在高速离心作用下,形成了大量的泡沫,有利于浓浆脱气,为后续的静置、减少浓浆气泡奠定了基础;
(3)杀菌;
所述杀菌为将胶磨后浆液升温杀菌,温度80~95℃,时间30~60min;升温杀菌也有利于脱气;
所述杀菌也可以采用超高温瞬时杀菌工艺:温度120~135℃,时间10~30s;
杀菌必要时可加入消泡剂乳化硅油,用量0.3‰~1‰;
(4)静置;
所述静置为杀菌后浆液静置30~35min,最好保持温度90~92℃;罐内的蒸气可从安全阀中放出;
(5)灌装;
所述灌装温度80~85℃;灌装浓度一般70~75%;
(6)冷却;
所述冷却为灌装后浓浆在常温下至少放置15min,然后,再水浴冷却,主要是为避免因浓浆温度太高遇水迅速冷却后,急剧产生泡沫,水浴温度25~30℃;
水浴冷却主要目的:①瓶盖内胶皮垫的抗热性并不是很好,长时间的高温,会使瓶内的胶垫其物理性能有所改变,即对瓶子的气密性有影响,所以要及时降温;②及时降温,会使瓶子内在短时间内形成真空,有效地保证了产品的质量;③水浴冷却时,灌装时瓶子外壁粘有的少量糖液,会在水中溶解,使瓶子外壁保持相对干净,不受微生物的感染;
(7)包装。
所述浓缩枣汁生产方法包括:
原料分选:挑选无虫害、无鼠咬、无霉烂、无变质枣果;把好原料关,是确保产品质量的重要环节;所述枣优选为有机转换红枣;
清洗与浸泡:将枣置40~50℃温水中清洗干净;清洗过程中可进一步挑选去除不合格枣;可选用带有叶轮的清洗缸为清洗设备;所述浸泡为将清洗后枣置40~50℃温水中浸泡10~60min;一般可按干枣∶水=1∶3~10比例进行浸泡;浸泡有益效果:浸泡可使枣果吸水膨胀、软化,有利于提高出汁率;
微波处理:将浸泡处理过的红枣进行微波处理,微波功率为400~800w,时间为1~15min;在微波处理下,红枣细胞组织由于相互间的高速运动和摩擦而破碎,细胞溃解使内容物溢出,从而提高红枣的出汁率;微波处理还可以增加红枣果香和色泽,香味更加浓郁;
浸提:为超声助提,料水比一般为1∶1~10;超声频率40~100khz,优选60~80khz,提取温度85~95℃,时间1~2h;传统的热水浸提枣汁方法由于提取温度较高,提取时间较长,红枣营养成分损失严重,影响了枣汁的营养和风味;超声助提方法能够减少提取时间,提高浸提效率和枣汁品质;
枣汁分离:浸提后趁热过滤,温度优选65~80℃;可选用双联过滤器,80目的过滤网;趁热过滤流速快,解决了因枣汁中果胶等物质含量高,易发生堵塞,造成过滤困难的技术问题;
浓缩:先采用三效旋转流降膜浓缩至30~40°Bx,其中一效温度控制在90~95℃,真空度-0.02Mpa,二效温度控制在80~85℃,真空度-0.06Mpa,三效温度控制在55~60℃,真空度-0.09Mpa;再采用单效浓缩至65°Bx以上,单效浓缩时真空度0.06~0.08MPa;浓缩后得浓缩枣汁;
流体浓缩工艺较多,常见的有常压浓缩、单效或多效升膜浓缩、单效或多效降膜浓缩、膜浓缩、冷冻浓缩等工艺方式,根据红枣汁物料特性和工业化实现的可能性以及综合能耗,选用三效旋转流降膜浓缩工艺及装置,可有效地避免枣汁在浓缩过程中易粘壁焦糊的现象,大大提高了浓缩效率,降低了能源消耗;采用三效旋转流降膜浓缩与单效浓缩相结合的技术方案,可提高枣汁浓度,避免黏糊及糊壁现象,减少浪费,提升枣汁质量;
红枣含有丰富的营养成份,具有补中益气,坚志强力的功效,具有很高的营养保健价值。《神农本草经》记载,枣味甘、性平、无毒,缓和药性,久服轻身延年益寿。《名医别录》记载:“红枣具有补中益气、养胃健脾等作用”。现代研究表明,枣含有丰富的蛋白质、糖类、有机酸、脂肪、多种氨基酸、维生素、微量元素(如铁、锰、锌、钼、铬)、环腺苷酸及生物碱、皂甙、黄酮等有效成份。枣属低热量食物,并富含膳食纤维、钾等促进新陈代谢、降脂、排便的成分,有助于保护心脑血管。此外,红枣作为含铁丰富的食物,其补血补气的作用已为世人所熟知。大枣其可口的酸甜滋味,能缓解孕妇妊娠期常见的恶心、呕吐、食欲不振等现象。红枣具有明显的免疫促进活性。大量药理和临床实验研究表明,多糖类化合物是一种免疫调节剂,能激活免疫细胞,提高机体的免疫功能。
研究表明,孕妇需要的营养素主要是蛋白质、糖类、脂肪、维生素、叶酸和微量元素。帮助改善孕妇营养状况,改善孕妇贫血症状,食补更安全有效。伴随着从孕中期开始的孕妇血容量和血红蛋白的增加,孕妇成为缺铁性贫血的高危人群,基于胎儿铁储备的需要,孕前女性应储备足够的铁为孕期利用,同时在孕中期开始增加铁的摄入量。因此,准妈妈常吃含铁丰富的实物,可以预防贫血并有利于母婴健康。孕妇补充营养的最好途径是食物,孕妈咪应尽量避免药物成分的摄入,才能使即将出生的宝宝健康聪明,大红枣作为含铁丰富的食物,其补血补气的作用已为世人所熟知,成为准妈妈每日必备的营养餐。孕产妇成为缺铁性贫血的高危人群。基于胎儿铁储备的需要,孕前女性应储备足够的铁为孕期利用,同时在孕中期开始增加铁的摄入量。
铁:是人体内含量最多的微量元素,主要以铁蛋白和含铁血红素存在于肝、脾和骨骼内。孕前缺铁易导致早产、孕期母体体重增长不足以及新生儿低出生体重。缺铁性贫血也是妊娠期最常见的一种并发症,在妊娠后半期约有25%的孕妇因吸收不良,或因来源缺乏致使铁的摄入量不足,产生缺铁性贫血。
钙:是人体中含量最高的无机元素之一,它分布在人体全身的各个部位,是构成骨骼、牙齿的重要物质,也用于调节肌肉的收缩与舒张,帮助血液凝固、神经传递等重要生理功能。孕妇缺钙表现为牙齿松动、四肢无力、经常抽筋、麻木;腰酸背疼、关节疼、风湿疼;头晕并罹患贫血、产前高血压综合症、水肿及乳汁分泌不足。
锌:在生命活动中,锌起着转运物质和能量代谢的″生命齿轮″作用。孕妇缺锌,胎儿的畸形率会增高。
叶酸:妊娠的头4周是胎儿神经管分化和形成的重要时期,此期叶酸缺乏可增加胎儿发生神经管畸形及早产的危险。特别强化叶酸,可降低胎儿神经管畸形的发生率及早产的危险。帮助促进排便,孕妇肠道健康的好伴侣。育龄妇女应从计划妊娠开始尽可能早地多摄取富含叶酸的食物及从孕前3个月开始每日补充叶酸400μg,并持续至整个孕期。
牛磺酸:牛磺酸具有多种生理功能,是人体健康必不可少的一种营养素。主要生理功能:促进婴幼儿脑组织和智力发育,牛磺酸在脑内的含量丰富、分布广泛,能明显促进神经系统的生长发育和细胞增殖、分化,且呈剂量牛磺酸依赖性,在脑神经细胞发育过程中起重要作用。研究表明:早产儿脑中的牛磺酸含量明显低于足月儿,这是因为早产儿体内的半肤氨酸亚磺酸脱氢酶(CSAD)尚未发育成熟,合成牛磺酸不足以满足机体的需要,需由母乳补充。母乳中的牛磺酸含量较高,尤其初乳中含量更高。如果补充不足,将会使幼儿生长发育缓慢、智力发育迟缓。牛磺酸与幼儿、胎儿的中枢神经及视网膜等的发育有密切的关系,长期单纯的牛奶喂养,易造成牛磺酸的缺乏;提高神经传导和视觉机能;防止心血管病;影响脂类的吸收;改善内分泌状态,增强人体免疫;影响糖代谢;改善记忆的功能;牛磺酸防治缺铁性贫血有明显效果,它不仅可以促进肠道对铁的吸收,还可增加红细胞膜的稳定性;牛磺酸还是人体肠道内双歧菌的促生因子,优化肠道内细菌群结构;还具有抗氧化、延缓衰老作用。
磷脂:是一类含有磷酸的脂类,机体中主要含有两大类磷脂,由甘油构成的磷脂称为甘油磷脂(phosphoglyceride);由神经鞘氨醇构成的磷脂,称为鞘磷脂(sphingolipid)。磷脂是生命基础物质。人体所有细胞中都含有磷脂,它是维持生命活动的基础物质。磷脂对活化细胞,维持新陈代谢,基础代谢及荷尔蒙的均衡分泌,增强人体的免疫力和再生力,都能发挥重大的作用。磷脂的基本功用是:增强脑力,安定神经,平衡内分泌,提高免疫力和再生力,解毒利尿,清洁血液,健美肌肤,保持年轻,延缓衰老;乳化作用;增智,可以加快神经细胞和大脑细胞间信息传递的速度,增加记忆力,预防老年痴呆;活化细胞。
维生素A:又称视黄醇(其醛衍生物视黄醛)是一个具有酯环的不饱和一元醇。生理功能:1)维持正常视觉功能;2)维护上皮组织细胞的健康;3)维持骨骼正常生长发育;4)促进生长与生殖;5)其他:近年发现维生素A酸(视黄酸)类物质有延缓或阻止癌前病变,防止化学致癌剂的作用,特别是对于上皮组织肿瘤,临床上作为辅助治疗剂已取得较好效果。β-胡萝卜素具有抗氧化作用,近年来有大量报道,是机体一种有效的捕获活性氧的抗氧化剂,对于防止脂质过氧化,预防心血管疾病、肿瘤,以及延缓衰老均有重要意义。维生素A对于机体免疫功能有重要影响,缺乏时,细胞免疫呈现下降。
维生素D3:又名烟碱酸胺、胆骨化醇。主要有以下生理功能:提高肌体对钙、磷的吸收,使血浆钙和血浆磷的水平达到饱和程度;促进生长和骨骼钙化,促进牙齿健全;通过肠壁增加磷的吸收,并通过肾小管增加磷的再吸收;维持血液中柠檬酸盐的正常水平;维生素D3是活性的7-脱氢胆固醇。
二十二碳六烯酸(docosahexaenoic acid,DHA)和二十碳四烯酸(arachidonic acid,AA)是母乳中天然存在的两种婴儿发育非常重要的不饱和脂肪酸,在人体中有着广泛的生理活性。DHA的生理功能突出表现在其能够促进胎儿和婴幼儿的神经系统发育。DHA是ω-3系中惟一可以通过胎盘的不饱和脂肪酸,经胎盘进入胎儿脑部的DHA可提供胎儿脑细胞分裂所需,健全胎儿脑细胞组织。DHA和AA是婴儿大脑和视网膜的重要组成部分,被认为是人类早期发育的必需营养素,对婴儿发育非常重要,如利于中枢神经系统的发育,视网膜的发育,智力、和认知能力和解决问题能力的发育,脉管系统的发育等。在人的整个一生中支持大脑、眼睛和心血管系统的健康,是维护大脑及视网膜正常发育及其功能稳定性所必需的。对维持和改善视力、提高记忆力、学习能力,以及抑制早、老年痴呆症的生理效果具有明显的作用。有越来越多的科学证据表明所有年龄段的人,从婴儿到成人都因为在日常饮食中摄入充足的DHA而获益。
粗多糖:是红枣自身具有的天然物质,它参与细胞的接触,激活,分裂等重要生命活动。粗多糖具有贮藏生物能和支持结构的作用;使人体分泌更多的免疫抗病因子,增强人体的免疫抗病能力。红枣多糖有可能通过诱导机体造血基质细胞和脾细胞等产生类造血生长因子物质,促进造血干细胞和祖细胞的分化增殖,而且促使基质细胞粘附性增加,有助于基质细胞和造血细胞的相互作用。孕妇在怀孕期间因自身免疫能力较弱,易感冒,而粗多糖恰恰能增强孕妇自身的免疫抗病能力,增强抵抗力。红枣富含的粗多糖又是天然形成的营养物质,更适合孕妈咪们的营养需求,只有免疫能力增强的孕妈咪才能生出聪明健康的好宝宝。
大枣所含环腺苷酸(camp)能阻止血小板内血栓素A2的形成,减少血小板的聚集,具有明显的抗血栓形成作用。
膳食纤维:是风靡世界的第七大营养素,它能促进肠蠕动,及时排除有害物质,具有抑制淀粉酶的作用,从而预防便秘、肥胖等,为女性保持窈窕身材的有益营养素,被誉为人体中的“专业清道夫”。枣富含膳食纤维,对孕妇清肠通便大有益处,是孕妇肠道健康的好伴侣。
现有孕妇相关产品营养保健产品多为单纯复合营养素补充剂类或中药材类,各原料混合一起,其配方不尽合理,没有全面考虑产品营养性与适口性,没有考虑各原料之间相互协调、相互影响的有机联系。本发明针对我国目前孕妇营养状况,以现代营养科学理论为指导,精选孕妇所需营养素,以药食同源的浓缩枣汁为载体,合理搭配组方,研制开发出即营养全面、功能协调,有具有很好适口性、有助于孕妇健脾益胃、调理肠胃、带来好胃口的红枣浓浆新型产品。各营养素经过科学配伍,采用现代食品加工工艺加工而成,充分发挥其协同作用,达到全面改善孕妇营养状况、补血补气、调节肠道、提高机体免疫力等功能作用,便于服用、便于携带、利于吸收。长期食用本发明红枣浓浆有利于提高孕妇营养水平,保证胎儿正常发育,减少孕妇并发症,降低低体重儿童、畸形儿出生率,有利于提高人口素质。
本发明所述适合孕妇食用的红枣浓浆也适合乳母和准备怀孕的妇女食用。
本发明适合孕妇食用的红枣浓浆产品食用方法:即可以直接食用,也可根据个人需求用冷、热开水冲调,或加入到牛奶、奶茶等中食用。推荐日食用量10~100g。
具体实施方式
以下实施例对本发明做进一步的说明。
实施例1
一种适合孕妇食用的红枣浓浆,含有DHA 0.8%、AA 0.1%、磷脂1%、维生素A 0.00005%、维生素D3 0.000005%、叶酸0.01%、牛磺酸0.1%、钙0.5%、铁0.5%、锌0.5%,余量为浓缩枣汁,总量为100%。
一种适合孕妇食用的红枣浓浆生产工艺,包括以下步骤:
(1)调配:按配方准确称取各原料,将DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌分别或几种混合后用适量(一般可为5~10倍重量)浓缩枣汁溶解、混匀,再加入到加热至75~80℃左右的浓缩枣汁中,搅拌均匀;
(2)胶磨:用胶体磨研磨;胶磨前最好要确保料液的固形物含量70~75°Bx;调整磨盘刻度到最佳时,开始胶磨;胶磨完成后,把磨盘调松,用冷水冲洗干净,以备下次使用;
(3)杀菌:将胶磨后浆液升温杀菌,温度80~95℃,时间30~60min;
所述杀菌也可以采用超高温瞬时杀菌工艺:温度120~135℃,时间10~30s;
杀菌必要时可加入消泡剂乳化硅油,用量0.3‰~1‰;
(4)静置:杀菌后浆液静置30~35min,最好保持温度90~92℃;罐内的蒸气可从安全阀中放出;
(5)灌装:灌装温度80~85℃;灌装浓度一般70~75%;
(6)冷却:灌装后浓浆在常温下至少放置15min,然后,再水浴冷却,水浴温度25~30℃;
(7)包装。
所述浓缩枣汁生产方法包括:
原料分选:挑选无虫害、无鼠咬、无霉烂、无变质枣果;
清洗与浸泡:将枣置40~50℃温水中清洗干净;清洗过程中可进一步挑选去除不合格枣;可选用带有叶轮的清洗缸为清洗设备;将清洗后枣置40~50℃温水中浸泡30min;可按干枣∶水=1∶10比例进行浸泡;
微波处理:将浸泡处理过的红枣进行微波处理,微波功率为600w,时间为10min;
浸提:为超声助提,料水比为1∶10;超声频率80khz,提取温度85~95℃,时间1h;
枣汁分离:浸提后趁热过滤,温度优选65~80℃;可选用双联过滤器,80目的过滤网;
浓缩:先采用三效旋转流降膜浓缩至30~35°Bx,其中一效温度控制在90~95℃,真空度-0.02Mpa,二效温度控制在80~85℃,真空度-0.06Mpa,三效温度控制在55~60℃,真空度-0.09Mpa;再采用单效浓缩至65°Bx以上,单效浓缩时真空度0.06~0.08MPa;浓缩后得浓缩枣汁。
实施例2
一种适合孕妇食用的红枣浓浆,含有DHA 0.1%、AA 0.5%、磷脂0.1%、维生素A 0.002%、维生素D3 0.00002%、叶酸0.005%、牛磺酸0.5%、钙0.8%、铁0.05%、锌0.05%,余量为浓缩枣汁,总量为100%。
一种适合孕妇食用的红枣浓浆生产工艺,同实施例1。
所述浓缩枣汁生产方法同实施例1。
实施例3
一种适合孕妇食用的红枣浓浆,含有DHA 0.2%、AA 0.4%、磷脂0.3%、维生素A 0.0001%、维生素D3 0.00001%、叶酸0.0001%、牛磺酸1.0%、钙1.5%、铁0.1%、锌0.1%,余量为浓缩枣汁,总量为100%;配方中还含有白砂糖10%、高果糖浆15%、柠檬酸1%、葡萄糖1%、蜂蜜0.5%中的一种或几种。
一种适合孕妇食用的红枣浓浆生产工艺,包括以下步骤:
(1)调配:先将白砂糖、高果糖浆、柠檬酸、葡萄糖、蜂蜜中的一种或几种与浓缩枣汁混合均匀后,再将DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌分别或几种混合后用适量(一般可为5~10倍重量)浓缩枣汁溶解、混匀,再加入到加热至75~80℃左右的浓缩枣汁中,搅拌均匀;
(2)胶磨:用胶体磨研磨;胶磨前最好要确保料液的固形物含量70~75°Bx;调整磨盘刻度到最佳时,开始胶磨;胶磨完成后,把磨盘调松,用冷水冲洗干净,以备下次使用;
(3)杀菌:将胶磨后浆液升温杀菌,温度80~95℃,时间30~60min;升温杀菌也有利于脱气;
所述杀菌也可以采用超高温瞬时杀菌工艺:温度120~135℃,时间10~30s;
杀菌必要时可加入消泡剂乳化硅油,用量0.3‰~1‰;
(4)静置:杀菌后浆液静置30~35min,最好保持温度90~92℃;罐内的蒸气可从安全阀中放出;
(5)灌装:灌装温度80~85℃;灌装浓度一般70~75%;
(6)冷却:灌装后浓浆在常温下至少放置15min,然后,再水浴冷却,水浴温度25~30℃;
(7)包装。
所述浓缩枣汁生产方法包括:
原料分选:挑选无虫害、无鼠咬、无霉烂、无变质枣果;
清洗与浸泡:将枣置40~50℃温水中清洗干净;清洗过程中可进一步挑选去除不合格枣;可选用带有叶轮的清洗缸为清洗设备;将清洗后枣置40~50℃温水中浸泡50min;可按干枣∶水=1∶5比例进行浸泡;
微波处理:将浸泡处理过的红枣进行微波处理,微波功率为800w,时间为5min;
浸提:为超声助提,料水比为1∶5;超声频率60khz,提取温度85~95℃,时间2h;
枣汁分离:浸提后趁热过滤,温度优选70~75℃;可选用双联过滤器,80目的过滤网;
浓缩:先采用三效旋转流降膜浓缩至30~40°Bx,其中一效温度控制在90~95℃,真空度-0.02Mpa,二效温度控制在80~85℃,真空度-0.06Mpa,三效温度控制在55~60℃,真空度-0.09Mpa;再采用单效浓缩至65°Bx以上,单效浓缩时真空度0.06~0.08MPa;浓缩后得浓缩枣汁。
实施例4
一种适合孕妇食用的红枣浓浆,含有DHA 0.6%、AA 0.2%、磷脂0.2%、维生素A 0.001%、维生素D3 0.00002%、叶酸0.008%、牛磺酸1.2%、钙1.5%、铁0.08%、锌0.08%,余量为浓缩枣汁,总量为100%;配方中还含有白砂糖15%、高果糖浆25%、柠檬酸3%、葡萄糖5%、蜂蜜0.1%中的一种或几种。
一种适合孕妇食用的红枣浓浆生产工艺,同实施例3。
所述浓缩枣汁生产方法同实施例1。
实施例5
一种适合孕妇食用的红枣浓浆,含有DHA 0.5%、AA 0.3%、磷脂0.5%、维生素A 0.001%、维生素D3 0.00002%、叶酸0.01%、牛磺酸1.0%、钙1.0%、铁0.05%、锌0.1%、白砂糖25%、高果糖浆10%、柠檬酸6%、葡萄糖3%、蜂蜜0.2%,余量为浓缩枣汁,总量为100%。
一种适合孕妇食用的红枣浓浆生产工艺,同实施例3。
所述浓缩枣汁生产方法同实施例1。
实施例6
一种适合孕妇食用的红枣浓浆,含有DHA 0.5%、AA 0.3%、磷脂0.8%、维生素A 0.002%、维生素D3 0.000015%、叶酸0.0006%、牛磺酸0.3%、钙0.5%、铁0.008%、锌0.01%、白砂糖15%、高果糖浆25%、柠檬酸3%,余量为浓缩枣汁,总量为100%。
一种适合孕妇食用的红枣浓浆生产工艺,同实施例3。
所述浓缩枣汁生产方法同实施例3。
实施例7
一种适合孕妇食用的红枣浓浆,含有DHA 0.8%、AA 0.1%、磷脂0.6%、维生素A 0.0002%、维生素D3 0.00001%、叶酸0.001%、牛磺酸1.5%、钙1%、铁0.005%、锌0.005%,余量为浓缩枣汁,总量为100%。
一种适合孕妇食用的红枣浓浆生产工艺,同实施例1。
所述浓缩枣汁生产方法同实施例1。
以实施例5红枣浓浆产品为样品,选择太原地区30名年龄22~30岁待孕期和怀孕期女性进行为期5个月的食用效果试验,每人每日食用量50~100g。试验过程中尽量不食用或少食用正常饮食外的其他营养保健品。结果:在试验过程中,食用者精神状况、食欲、消化情况、睡眠情况、体力均未见异常;食用者免疫力增强,身体健康,精神状态明显改善,未出现营养素缺乏症状。
Claims (5)
1.一种适合孕妇食用的红枣浓浆,其特征在于,含有DHA 0.1%~0.8%、AA 0.1%~0.5%、磷脂0.1%~1%、维生素A 0.00005%~0.002%、维生素D3 0.000005%~0.00002%、叶酸0.0001%~0.01%、牛磺酸0.1%~1.5%、钙0.5%~1.5%、铁0.005%~0.5%、锌0.005%~0.5%,余量为浓缩枣汁,总量为100%。
2.根据权利要求1所述的适合孕妇食用的红枣浓浆,其特征在于,还含有白砂糖10%~25%、高果糖浆10%~25%、柠檬酸1%~6%、葡萄糖1%~5%、蜂蜜0.1%~0.5%中的一种或几种。
3.根据权利要求1或2所述的适合孕妇食用的红枣浓浆,其特征在于,所述浓缩枣汁生产方法包括:
原料分选:挑选无虫害、无鼠咬、无霉烂、无变质枣果;
清洗与浸泡:将枣置40~50℃温水中清洗干净;清洗过程中可进一步挑选去除不合格枣;所述浸泡为将清洗后枣置40~50℃温水中浸泡10~60min;按干枣∶水=1∶3~10比例进行浸泡;
微波处理:将浸泡处理过的红枣进行微波处理,微波功率为400~800w,时间为1~15min;
浸提:为超声助提,料水比一般为1∶1~10;超声频率40~100khz,提取温度85~95℃,时间1~2h;
枣汁分离:浸提后趁热过滤,温度优选65~80℃;
浓缩:先采用三效旋转流降膜浓缩至30~40°Bx,其中一效温度控制在90~95℃,真空度-0.02Mpa,二效温度控制在80~85℃,真空度-0.06Mpa,三效温度控制在55~60℃,真空度-0.09Mpa;再采用单效浓缩至65°Bx以上,单效浓缩时真空度0.06~0.08MPa;浓缩后得浓缩枣汁。
4.一种制备如权利要求1所述适合孕妇食用的红枣浓浆的生产工艺,其特征在于,包括以下步骤:
(1)调配;
所述调配为按配方准确称取各原料,将DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌分别或几种混合后用适量浓缩枣汁溶解、混匀,再加入到加热至75~80℃的浓缩枣汁中,搅拌均匀;
(2)胶磨;
所述胶磨为用胶体磨研磨;调整磨盘刻度,开始胶磨;
(3)杀菌;
所述杀菌为将胶磨后浆液升温杀菌,温度80~95℃,时间30~60min;
(4)静置;
所述静置为杀菌后浆液静置30~35min,保持温度90~92℃;
(5)灌装;
所述灌装温度80~85℃;灌装浓度70~75%;
(6)冷却;
所述冷却为灌装后浓浆在常温下至少放置15min,然后,再水浴冷却,水浴温度25~30℃;
(7)包装。
5.一种制备如权利要求2所述适合孕妇食用的红枣浓浆的生产工艺,其特征在于,包括以下步骤:
(1)调配;
所述调配为先将白砂糖、高果糖浆、柠檬酸、葡萄糖、蜂蜜中的一种或几种与浓缩枣汁混合均匀后,再将DHA、AA、磷脂、维生素A、维生素D3、叶酸、牛磺酸、钙、铁、锌分别或几种混合后用适量浓缩枣汁溶解、混匀,再加入到加热至75~80℃左右的浓缩枣汁中,搅拌均匀;
(2)胶磨;
所述胶磨为用胶体磨研磨;调整磨盘刻度,开始胶磨;
(3)杀菌;
所述杀菌采用超高温瞬时杀菌工艺:温度120~135℃,时间10~30s;杀菌必要时加入消泡剂乳化硅油,用量0.3‰~1‰;
(4)静置;
所述静置为杀菌后浆液静置30~35min,保持温度90~92℃;
(5)灌装;
所述灌装温度80~85℃;灌装浓度70~75%;
(6)冷却;
所述冷却为灌装后浓浆在常温下至少放置15min,然后,再水浴冷却,水浴温度25~30℃;
(7)包装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104608455A CN102511858A (zh) | 2011-12-29 | 2011-12-29 | 一种适合孕妇食用的红枣浓浆及其生产工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104608455A CN102511858A (zh) | 2011-12-29 | 2011-12-29 | 一种适合孕妇食用的红枣浓浆及其生产工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102511858A true CN102511858A (zh) | 2012-06-27 |
Family
ID=46283164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104608455A Pending CN102511858A (zh) | 2011-12-29 | 2011-12-29 | 一种适合孕妇食用的红枣浓浆及其生产工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102511858A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105211985A (zh) * | 2015-11-04 | 2016-01-06 | 广东嘉豪食品有限公司 | 一种果葡糖浆与蔗糖协同制备高品质果汁浓浆的方法 |
| CN105747049A (zh) * | 2016-04-25 | 2016-07-13 | 秦朝东 | 防治产后发热的饮料及其制备方法 |
| CN106689360A (zh) * | 2015-08-05 | 2017-05-24 | 内蒙古伊利实业集团股份有限公司 | 一种益生发酵乳及其制备方法 |
| US11229095B2 (en) | 2014-12-17 | 2022-01-18 | Campbell Soup Company | Electromagnetic wave food processing system and methods |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070012589A (ko) * | 2005-07-23 | 2007-01-26 | 조계연 | 버섯음료의 제조방법 |
| CN101133831A (zh) * | 2007-09-05 | 2008-03-05 | 太原市汉波食品工业有限公司 | 新型浓缩营养枣汁饮料及其制作方法 |
| CN101283821A (zh) * | 2007-04-09 | 2008-10-15 | 山西木枣精华生物科技有限公司 | 一种制取木枣精华浓缩营养液的方法 |
| CN101433240A (zh) * | 2007-11-16 | 2009-05-20 | 光明乳业股份有限公司 | 一种适合孕妇和乳母食用的牛奶及其制备方法 |
-
2011
- 2011-12-29 CN CN2011104608455A patent/CN102511858A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070012589A (ko) * | 2005-07-23 | 2007-01-26 | 조계연 | 버섯음료의 제조방법 |
| CN101283821A (zh) * | 2007-04-09 | 2008-10-15 | 山西木枣精华生物科技有限公司 | 一种制取木枣精华浓缩营养液的方法 |
| CN101133831A (zh) * | 2007-09-05 | 2008-03-05 | 太原市汉波食品工业有限公司 | 新型浓缩营养枣汁饮料及其制作方法 |
| CN101433240A (zh) * | 2007-11-16 | 2009-05-20 | 光明乳业股份有限公司 | 一种适合孕妇和乳母食用的牛奶及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 杨晓波,等: "孕妇的营养和食物", 《中国乳业》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11229095B2 (en) | 2014-12-17 | 2022-01-18 | Campbell Soup Company | Electromagnetic wave food processing system and methods |
| CN106689360A (zh) * | 2015-08-05 | 2017-05-24 | 内蒙古伊利实业集团股份有限公司 | 一种益生发酵乳及其制备方法 |
| CN105211985A (zh) * | 2015-11-04 | 2016-01-06 | 广东嘉豪食品有限公司 | 一种果葡糖浆与蔗糖协同制备高品质果汁浓浆的方法 |
| CN105211985B (zh) * | 2015-11-04 | 2017-09-29 | 广东嘉豪食品有限公司 | 一种果葡糖浆与蔗糖协同制备高品质果汁浓浆的方法 |
| CN105747049A (zh) * | 2016-04-25 | 2016-07-13 | 秦朝东 | 防治产后发热的饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102511861A (zh) | 一种添加低聚糖的红枣浓浆 | |
| CN106690290A (zh) | 一种高膳食纤维全营养特殊医学用途配方食品及其制备方法 | |
| CN102511864B (zh) | 一种红枣浓浆 | |
| CN101156685A (zh) | 营养保健粥 | |
| CN105707707A (zh) | 藜麦孕产妇超级营养粉 | |
| CN104171025A (zh) | 一种适合妇女儿童的富硒食用油 | |
| CN102389053A (zh) | 一种低胆固醇、富硒、富胡萝卜素鸡蛋的生产方法 | |
| CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
| CN107581599A (zh) | 一种供产妇自然分娩时食用含短肽的特殊膳食用食品配方 | |
| CN103750464B (zh) | 一种山菇益智功能饮料及其制备方法 | |
| CN102511881A (zh) | 核桃红枣浓浆 | |
| CN104336144A (zh) | 一种同步调节高血糖高血压高血脂及免疫功能的食用饼干 | |
| CN102551139A (zh) | 红枣黄芪减肥浓浆 | |
| CN107801936A (zh) | 一种分散均匀、促进泌乳的组合物及其制备方法 | |
| CN102511858A (zh) | 一种适合孕妇食用的红枣浓浆及其生产工艺 | |
| CN105432792A (zh) | 一种学龄前儿童基础营养奶粉、营养粉套装及制备方法 | |
| CN104605020A (zh) | 一种保健复合酸牛奶及其制备方法 | |
| CN102511860B (zh) | 一种添加植物甾醇适合孕妇食用的红枣浓浆 | |
| CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
| CN102511879B (zh) | 红枣龟苓浓浆 | |
| CN102511875A (zh) | 一种适合术后人群饮用的红枣浓浆 | |
| CN108669384A (zh) | 一种适合幼儿期儿童饮用的水果粗粮饮料 | |
| CN102511859A (zh) | 一种添加dha适合孕妇乳母食用的红枣浓浆 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| CN105145738A (zh) | 一种孕妇营养饼干及生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20120627 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |